SEC Form 4 · accession 0001062993-18-002795
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vered Caplan
Officer — CEO
Period of report
Jun 28, 2018
Accepted (ET)
Jul 3, 2018 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $8.36 | Jun 28, 2018 | A | 250,000 | A | Dec 28, 2018 | Jun 28, 2028 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The options were awarded under the Issuer's 2017 Equity Incentive Plan and are scheduled to vest in two equal installments of 125,000 option shares on each of December 28, 2018 and June 28, 2019 and are exercisable at a per share exercise price of $8.36.